Cargando…
Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors
Cancer cells have altered cellular metabolism. Mutations in genes associated with key metabolic pathways (e.g., isocitrate dehydrogenase 1 and 2, IDH1/IDH2) are important drivers of cancer, including central nervous system (CNS) tumors. Therefore, we hypothesized that the abnormal metabolic state of...
Autores principales: | Ballester, Leomar Y., Lu, Guangrong, Zorofchian, Soheil, Vantaku, Venkatrao, Putluri, Vasanta, Yan, Yuanqing, Arevalo, Octavio, Zhu, Ping, Riascos, Roy F., Sreekumar, Arun, Esquenazi, Yoshua, Putluri, Nagireddy, Zhu, Jay-Jiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117959/ https://www.ncbi.nlm.nih.gov/pubmed/30170631 http://dx.doi.org/10.1186/s40478-018-0588-z |
Ejemplares similares
-
Detection of the MYD88 p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma
por: Zorofchian, Soheil, et al.
Publicado: (2018) -
Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors
por: Takayasu, Takeshi, et al.
Publicado: (2020) -
Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2017) -
Correction: Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
por: Vantaku, Venkatrao, et al.
Publicado: (2019) -
Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse
por: Arevalo, Octavio D., et al.
Publicado: (2019)